2018 ACOG实践简报:妇科手术后感染的预防

2018-06-01 美国妇产科医师学会 Obstet Gynecol. 2018 Jun;131(6):e172-e189.

2018年6月,美国妇产科医师学会(ACOG)发布了关于妇科手术后感染的预防的实践指南。手术部位感染仍然是妇科手术最常见的并发症,本文的主要介绍了妇科手术后感染的预防干预措施,包括抗生素预防。

中文标题:

2018 ACOG实践简报:妇科手术后感染的预防

英文标题:

ACOG Practice Bulletin No. 195: Prevention of Infection After Gynecologic Procedures.

发布机构:

美国妇产科医师学会

发布日期:

2018-06-01

简要介绍:

2018年6月,美国妇产科医师学会(ACOG)发布了关于妇科手术后感染的预防的实践指南。手术部位感染仍然是妇科手术最常见的并发症,本文的主要介绍了妇科手术后感染的预防干预措施,包括抗生素预防。 

拓展指南:感染相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 ACOG实践简报:妇科手术后感染的预防)] GetToolGuiderByIdResponse(projectId=1, id=4b8a81c001598899, title=2018 ACOG实践简报:妇科手术后感染的预防, enTitle=ACOG Practice Bulletin No. 195: Prevention of Infection After Gynecologic Procedures., guiderFrom=Obstet Gynecol. 2018 Jun;131(6):e172-e189., authorId=null, author=, summary=2018年6月,美国妇产科医师学会(ACOG)发布了关于妇科手术后感染的预防的实践指南。手术部位感染仍然是妇科手术最常见的并发症,本文的主要介绍了妇科手术后感染的预防干预措施,包括抗生素预防。 , cover=, journalId=null, articlesId=null, associationId=357, associationName=美国妇产科医师学会, associationIntro=美国妇产科医师学会(ACOG),前身为美国妇产科学院,是一个美国妇产科妇科专业医生的专业协会。ACOG拥有超过55000名会员,其中90% 的会员是在美国经执业认证的妇产科医生。Obstetrics & Gynecology是ACOG的官方刊物。通常被称为&ldquo;绿色杂志&rdquo;。 American College of Obstetricians and Gynecologists, copyright=0, guiderPublishedTime=Fri Jun 01 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年6月,美国妇产科医师学会(ACOG)发布了关于妇科手术后感染的预防的实践指南。手术部位感染仍然是妇科手术最常见的并发症,本文的主要介绍了妇科手术后感染的预防干预措施,包括抗生素预防。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>感染</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=d5f861c001586560" title="感染乙型肝炎病毒的育龄女性临床管理共识" target=_blank>感染乙型肝炎病毒的育龄女性临床管理共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=656511c001583af3" title="2018 ESGCD指南:急诊医疗中艰难梭菌感染的预防" target=_blank>2018 ESGCD指南:急诊医疗中艰难梭菌感染的预防</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=418e01c0015826de" title="2018 EBMT立场声明:造血干细胞移植后患者腺病毒感染的管理" target=_blank>2018 EBMT立场声明:造血干细胞移植后患者腺病毒感染的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=15e4e1c001582136" title="2018 ASGE指南:胃肠内镜检查期间感染控制" target=_blank>2018 ASGE指南:胃肠内镜检查期间感染控制</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=0f57d1c0015e77a1" title="2018 HHS指南:HIV感染的成人及青少年应用抗逆转录病毒药物治疗" target=_blank>2018 HHS指南:HIV感染的成人及青少年应用抗逆转录病毒药物治疗</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E6%84%9F%E6%9F%93" target=_blank>有关感染更多指南</a></ul>, tagList=[TagDto(tagId=56538, tagName=妇科手术), TagDto(tagId=8872, tagName=术后感染)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4339, appHits=205, showAppHits=0, pcHits=3037, showPcHits=1694, likes=92, shares=11, comments=3, approvalStatus=1, publishedTime=Sat Jun 02 21:59:47 CST 2018, publishedTimeString=2018-06-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Jun 02 21:59:47 CST 2018, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 09:29:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ACOG实践简报:妇科手术后感染的预防)])
2018 ACOG实践简报:妇科手术后感染的预防
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=954824, encodeId=6ad095482429, content=已看,还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:27:34 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321053, encodeId=15b0321053f6, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jun 03 07:15:57 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321010, encodeId=63403210104e, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jun 03 06:54:31 CST 2018, time=2018-06-03, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    已看,还可以。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=954824, encodeId=6ad095482429, content=已看,还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:27:34 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321053, encodeId=15b0321053f6, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jun 03 07:15:57 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321010, encodeId=63403210104e, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jun 03 06:54:31 CST 2018, time=2018-06-03, status=1, ipAttribution=)]
    2018-06-03 1dd8c52fm63(暂无匿称)

    了解了解.继续关注

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=954824, encodeId=6ad095482429, content=已看,还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:27:34 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321053, encodeId=15b0321053f6, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jun 03 07:15:57 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321010, encodeId=63403210104e, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jun 03 06:54:31 CST 2018, time=2018-06-03, status=1, ipAttribution=)]
    2018-06-03 飛歌

    厉害了我的哥

    0